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Background.  —  Elderly  patients  are  increasingly  referred  for  complex  percutaneous  coronary






Methods. —  Consecutive  patients  (n  =  356)  who  underwent  CTO-PCI  in  our  institution  between
January 2008  and  December  2011  were  prospectively  included.  The  short-term  outcomes  of
CTO-PCI were  assessed  by  comparing  the  rates  of  successful  recanalization  and  postoperative
Abbreviations: ACS, acute coronary syndrome; CAD, coronary artery disease; CTO, chronic total occlusion; MACCE, major adverse cardiac
or cerebrovascular event; MACE, major adverse cardiac event; PCI, percutaneous coronary intervention.
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complications  in  patients  aged  ≥75  years  and  those  <75  years.  The  clinical  effect  of  successful
recanalization  was  evaluated  in  a  20-month  follow-up  analysis  in  patients  ≥75  years.
Results. —  Although  patients  ≥75  years  (n  =  93)  had  more  complex  coronary  artery  disease,  the
procedural  success  rate  was  similar  to  that  in  younger  patients  (78.2%  vs.  74.3%,  respectively;
P =  0.41).  Postoperative  complications  were  more  frequent  in  older  patients  (5.4%  vs.  0.4%;
P =  0.005).  Major  adverse  cardiac  event-free  survival  analysis  at  20  months  revealed  that  suc-
cessful revascularization  was  indicative  of  a  better  prognosis  in  older  patients  (hazard  ratio:
0.43, 95%  conﬁdence  interval:  0.19—0.96;  P  =  0.039).
Conclusion.  —  Elderly  patients  have  more  complex  coronary  disease  and  are  at  a  higher  risk  of
postoperative  complications.  Nevertheless,  we  observed  a  similar  success  rate  for  CTO-PCI  in
elderly patients  as  for  younger  patients.  Successful  CTO  recanalization  improved  the  event-
free survival  rate  at  20  months.  Thus,  CTO-PCI  constitutes  an  alternative  strategy  for  treating
selected  elderly  patients.








Contexte.  —  Les  patients  âgés  sont  de  plus  en  plus  fréquemment  adressés  pour  angioplastie  de
lésions coronaires  complexes  comme  les  occlusions  coronaires  chroniques  (CTO).
Objectifs.  —  Évaluer  la  faisabilité,  la  sécurité  et  l’impact  pronostique  d’une  tentative
d’angioplastie  de  CTO  au  sein  d’une  population  de  patients  âgés.
Méthodes.  —  Nous  avons  inclus  les  356  patients  consécutifs  ayant  bénéﬁcié  d’une  angioplastie
de CTO  dans  le  CHU  de  Rangueil  entre  janvier  2008  et  décembre  2011.  À  court  terme,  la
faisabilité et  la  sécurité  des  procédures  ont  été  évaluées  en  comparant  le  taux  de  succès  et  le
taux de  complication  obtenus  à  30  jours  chez  les  patients  de  plus  et  de  moins  de  75  ans.  Chez
les patients  ≥  75  ans,  l’impact  pronostique  du  succès  de  la  revascularisation  a  été  évalué  par
une analyse  de  la  morbi-mortalité  à  20  mois.
Résultats.  —  Le  taux  de  succès  des  procédures  d’angioplastie  de  CTO  n’était  pas  signiﬁcative-
ment différent  chez  les  patients  ≥  75  ans  (n  =  93)  et  <  75  ans  (74,3  %  vs  78,2  %  ;  p  =  0,41).  Les
complications  post-angioplastie  étaient  néanmoins  plus  fréquentes  dans  le  groupe  ≥  75  ans  (5,4
% vs  0,4  %  ;  p  =  0,005).  À  20  mois,  un  succès  de  revascularisation  de  la  CTO  améliore  le  pronostic
des patients  âgés  en  réduisant  le  taux  d’événements  cardiovasculaires  majeurs  (HR  :  0,43  ;  IC
95 %  :  0,19—0,96  ;  p  =  0,039)  mais  sans  améliorer  signiﬁcativement  la  survie.
Conclusion.  — L’angioplastie  des  CTO  est  une  stratégie  de  revascularisation  qui  peut
raisonnablement  être  proposée  aux  patients  âgés  aﬁn  d’améliorer  leur  pronostic  cardiovas-
culaire à  moyen  terme.




























ife  expectancy  has  increased  in  recent  decades,  in  part
ue  to  medical  advances.  As  a  result,  more  elderly  patients
re  being  referred  to  cardiologists  for  treatment  of  coro-
ary  artery  disease  (CAD),  but  the  optimal  management
n  those  aged  75  years  and  older  is  debated.  Indeed,  the
eneﬁts  of  aggressive  revascularization  in  elderly  patients
ave  been  poorly  investigated  in  randomized  trials,  and
umerous  studies  have  reported  a  higher  risk  of  postop-
rative  complications  [1,2]  and  lower  procedural  success
ates  with  percutaneous  coronary  intervention  (PCI)  [3]  in
he  elderly.  Techniques  have  improved,  however,  and  evi-
ence  from  more  recent  studies  has  suggested  that  elderly
atients  could,  paradoxically,  beneﬁt  more  than  younger
atients  from  appropriate  interventional  revascularization
d
i
d4].  In  clinical  practice,  older  patients  still  have  the  lowest
ates  of  revascularization  [5]  and  this  is  especially  true  for
lderly  patients  with  chronic  total  coronary  occlusion  (CTO).
ndeed,  studies  have  shown  that  because  of  the  lower  suc-
ess  rates  of  recanalization  (60—70%),  a  minority  of  patients
ith  CTO  (8—15%)  are  referred  for  PCI  [6—9].
The  prevalence  of  CTO  rises  with  age  [10]  and  can
ffect  more  than  30%  of  older  patients  suspected  of  hav-
ng  myocardial  ischaemia  [7],  but  there  is  no  clear  evidence
n  the  best  way  to  manage  these  patients.  Indirect  evi-
ence  from  non-randomized  studies  suggests  that  CTO-PCI
ould  improve  survival  and  relieve  symptoms  related  to
yocardial  ischaemia  [11,12], but  there  is  a  paucity  of  data
escribing  CTO-PCI  among  the  elderly.  Moreover,  most  stud-
es  on  elderly  patients  were  carried  out  10  years  ago  [12]  and




















































iOutcomes  after  CTO-PCI  in  elderly  patients  
in  CTO-PCI  (including  widespread  use  of  drug-eluting  stents
and  CTO-dedicated  devices)  that  have  probably  improved
the  outcome  of  CTO-PCI  in  elderly  patients  [13].
The  aim  of  our  study  was  to  develop  a  comprehensive
single-centre  registry  including  all  patients  undergoing  CTO-
PCI  in  our  department,  to  evaluate  the  feasibility,  safety  and
outcomes  of  CTO-PCI  in  the  elderly  population  (≥75  years).
Methods
Population
All  consecutive  patients  referred  to  the  Rangueil  Univer-
sity  Hospital,  Toulouse,  France  for  PCI  of  a  chronically
occluded  native  coronary  vessel  between  January  2008  and
December  2011  were  included  in  the  registry.  Patients  were
divided  into  two  age  groups  (<75  and  ≥75  years).  A  CTO  was
angiographically  deﬁned  as  a  complete  occlusion  with  no
anterograde  ﬁlling  of  the  distal  vessel  within  the  occluded
segment  [14].  The  duration  of  occlusion  was  assessed  by
the  clinical  history  and  previous  angiograms.  All  patients
referred  for  PCI  had  myocardial  viability  in  the  territory  of
CTO  and  persistent  symptoms  related  to  ischaemia  despite
optimal  medical  therapy,  or  extensive  silent  myocardial
ischaemia  documented  by  stress  imaging  such  as  magnetic
resonance  imaging,  scintigraphy  or  echocardiography.  The
exclusion  criterion  was  an  estimated  CTO  duration  of  <3
months.
Data  on  patient  baseline  characteristics,  procedural
details  and  in-hospital  outcomes  were  collected  from  medi-
cal  records  and  a  database  by  a  trained  medical  investigator.
Quality  controls  were  performed  before  analysis.  Chronic
pulmonary  disease  was  deﬁned  as  the  long-term  use  of  bron-
chodilators  or  steroids  for  lung  disease  and  the  EuroSCORE
was  calculated  according  to  the  EuroSCORE  I  additive  sco-
ring  method.  Creatinine  clearance  was  calculated  according
to  the  Modiﬁcation  of  Diet  in  Renal  Disease  formula.  Mod-
erate  chronic  kidney  was  deﬁned  as  creatinine  clearance
between  30  and  59  mL/min  and  severe  disease  as  creatinine
clearance  <30  mL/min.  Symptoms  suggestive  of  congestive
heart  failure  were  classiﬁed  according  to  the  New  York  Heart
Association  (NYHA)  classiﬁcation  and  symptoms  of  angina
according  to  the  Canadian  Cardiovascular  Society  (CCS)  clas-
siﬁcation.  Left  ventricular  ejection  fraction  was  evaluated
by  echocardiography,  magnetic  resonance  imaging  or  ven-
triculography.
Procedures
Procedures  were  performed  according  to  the  operators’
standard  practices  via  a  radial  or  femoral  approach,  and  a
retrograde  approach  was  used  when  required.
Procedural  success  was  deﬁned  as  the  restoration  of  an
anterograde  ﬂow,  with  thrombosis  in  myocardial  infarction
(TIMI)  ﬂow  grade  2  or  3  and  a  residual  stenosis  of  <30%  on
angiography.End-points and follow-up
For  in-hospital  outcomes,  major  adverse  cardiac  and  cere-





f  death,  myocardial  infarction  or  stroke.  Haemorrhage  was
eﬁned  as  a  drop  in  haemoglobin  >3  g/dL  [15]  and  acute
enal  failure  as  a  >25%  rise  in  creatinine  within  the  ﬁrst
8  hours  following  PCI  [16,17].  The  performance  of  coronary
rtery  bypass  graft  surgery  within  30  days  was  also  recorded.
s  described  in  the  European  guidelines,  post-PCI  myocar-
ial  infarction  was  deﬁned  as  an  association  of  suggestive
ymptoms  or  electrocardiographic  changes  with  a signiﬁcant
levation  in  troponin  concentration  [18].
For  long-term  outcomes,  data  were  collected  annually
y  an  experienced  investigator  who  contacted  all  patients
or  a  telephone  interview.  To  complete  the  follow-up  qual-
ty  control,  medical  records  from  cardiologists  and  general
ractitioners  were  also  collected  and  the  data  compared
gainst  the  case  report  forms.  The  beneﬁts  of  revasculari-
ation  were  evaluated  at  20  months  by  comparing  event-free
urvival  rates  among  older  patients  according  to  the  initial
rocedural  outcome.  Events  were  then  deﬁned  as  death,
yocardial  infarction  and  a  need  for  revascularization  (PCI
r  coronary  artery  bypass  graft  surgery).  Patients  who  under-
ent  a  successful  second  CTO-PCI  attempt  within  3  months
fter  failure  of  the  ﬁrst  procedure  were  followed  up  from
he  date  of  the  second  PCI.  Planned  second  attempts  on  the
ame  lesion  within  3  months  were  not  recorded  as  events  in
he  failure  group.
The  study  protocol  was  approved  by  our  institutional
eview  board  and  all  patients  provided  informed  consent.
tatistical analysis
ll  continuous  variables  are  described  as  mean  and  standard
eviation  (SD)  or  median  and  interquartile  range  (IQR).
ategorical  variables  are  presented  as  proportions.  In  bivari-
te  analysis,  qualitative  variables  were  compared  using  the
hi-square  test  (or  the  Fisher’s  exact  test  when  neces-
ary).  Mean  values  of  quantitative  variables  were  compared
sing  Student’s  t test.  The  Shapiro-Wilks  and  the  Levene’s
ests,  respectively,  were  used  to  test  the  normality  of  the
ariables’  distributions  and  the  homogeneity  of  variances.
 non-parametric  Mann-Whitney  test  was  performed  when
asic  assumptions  of  the  Student’s  t test  were  not  satisﬁed.
The  association  between  patient  baseline  characteristics
nd  the  risk  of  a post-PCI  event  was  assessed  by  multivari-
ble  logistic  analysis.  The  model  was  built  by  applying  a
orward  procedure.  Included  variables  were  selected  based
n  the  scientiﬁc  literature.  Continuous  variables  fulﬁlled
og-linearity.
The  cumulative  survival  of  patients  according  to  pro-
edural  outcome  (success  or  failure)  was  determined  by
he  Kaplan-Meier  method  and  compared  using  the  log-rank
est.  The  relations  between  the  patient  baseline  charac-
eristics,  procedural  outcome  and  major  adverse  cardiac
vents  (MACE;  deﬁned  as  acute  coronary  syndromes,  cardio-
enic  shock,  new  percutaneous  coronary  revascularization
r  death)  at  20  months  were  assessed  using  Cox  propor-
ional  hazards  regression  analysis.  The  multivariable  model
as  built  by  applying  a  forward  procedure.  Variables  were
ncluded  in  the  model  if  their  P-value  was  <0.20  in  the  bivari-
te  analysis  or  if  they  were  clinically  pertinent.  All  included
ariables  met  the  hypothesis  of  risk  proportionality.  Contin-
ous  variables  also  fulﬁlled  log-linearity.  The  ﬁnal  model  was





































































































All  statistical  analyses  were  performed  using  STATA  v11.2
STATA  Corporation,  College  Station,  Texas).  For  all  tests,  a
-value  of  <0.05  was  considered  signiﬁcant.
esults
aseline characteristics
 total  of  374  CTO-PCIs  were  performed  in  356  patients.
inety-three  (26.1%)  of  the  patients  were  ≥75  years  old
median  age:  80  years,  IQR:  78—83).  Medical  history  and
revalence  of  cardiovascular  risk  factors  were  broadly  sim-
lar  in  the  two  age  groups,  but  older  patients  appeared  to
e  at  higher  risk  of  postoperative  complications  (Table  1).
ndeed,  they  tended  to  be  referred  more  frequently  for
cute  coronary  syndromes  (ACS)  related  to  other  lesions
40.9%  vs.  30.4%;  P  =  0.07),  and  they  had  higher  rates  of
hronic  renal  disease  (P  <  0.001)  and  symptoms  of  conges-
ive  heart  failure  on  admission  (P  =  0.014).  Angiographic
ndings  revealed  more  complex  and  more  extensive  CAD
n  older  patients:  55  (59%)  had  a  CTO  involving  the  left
nterior  descending  artery  and  78  (84%)  had  multivessel
isease.
rocedural characteristics
rocedural  characteristics  were  analysed  by  lesion  for  each
TO-PCI  attempt.  The  rate  of  arterial  access  was  similar  in
he  two  groups;  52.1%  vs.  52.5%  for  radial  access  (P  =  0.95),
9.2%  vs.  32.7%  for  femoral  access  (P  =  0.51),  and  18.7%  vs.
4.8%  for  both  (P  =  0.38),  in  younger  and  older  patients,
espectively.  However,  procedural  techniques  tended  to  dif-
er  between  groups:  retrograde  wire  crossing  techniques
ere  used  less  often  with  older  patients  (10.9%  vs.  29.4%;
 <  0.001)  but  complex  atherectomy  procedures  were  more
requent  (16.8%  vs.  2.8%;  P  <  0.001).
Overall  success  rates  were  78.2%  (n  =  226)  in  younger
atients  and  74.3%  (n  =  75)  in  older  patients  (P  =  0.42).  In
ases  of  procedural  success,  98.7%  of  patients  had  stent
mplantations.  Drug-eluting  stents  were  used  in  96.0%  of
ounger  patients  and  in  88.0%  of  older  patients  (P  =  0.011).
he  mean  ﬂuoroscopy  time  (56  ±  33  min  in  younger  patients
s.  52  ±  21  min  in  older  patients;  P  =  0.55)  and  the  procedural
ime  (107  ±  52  min  in  patients  under  75  years  vs.  97  ±  32  min
n  older  patients;  P  =  0.478)  were  similar  in  both  groups  but
he  volume  of  contrast  agent  used  was  higher  in  younger
atients  (281  ±  114  mL  vs.  235  ±  84  mL;  P  =  0.003).
utcomes at 30 days
he  30-day  outcome  data  are  presented  in  Table  2.
ates  of  MACCE  were  signiﬁcantly  higher  in  older  patients
5.4%  vs.  0.4%;  P  =  0.005).  One  death  was  recorded  in
oth  groups  for  patients  admitted  with  ACS  involving  a
essel  other  than  the  CTO  vessel.  Furthermore,  among
he  older  group,  one  patient,  referred  for  severe  con-
estive  heart  failure,  died  during  hospitalization.  Among
atients  ≥75  years,  other  post-procedural  complications
ere  post-PCI  myocardial  infarctions  (three  patients)  and
inor  complications  such  as  haemorrhage  or  transitional
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oronary  artery  bypass  surgery  within  30  days  after  the  PCI
ttempt,  but  both  cases  involved  elective  surgery  after  PCI
ailure.
After  adjustment  for  patient  baseline  characteristics
age,  sex,  history  of  chronic  kidney  disease,  ACS  at  admission
nd  multivessel  CAD),  the  strongest  predictors  of  post-PCI
vents  (composite  of  MACCE,  haemorrhage  or  acute  renal
ailure)  were  age  (OR:  1.1,  95%  CI:  1.05—1.18)  and  sex  (OR:
.98,  95%  CI:  1.44—10.93).
The  median  length  of  stay  was  5  days  (3—7)  for  patients
75  years  and  4  days  (3—5)  for  patients  <75  years  (P  =  0.01).
ong-term follow-up
he  long-term  outcomes  of  CTO  revascularization  were
ssessed  by  analysing  MACE-free  survival  according  to  CTO-
CI  outcome.  Analyses  were  conducted  in  patients  ≥75
ears,  in  whom  the  20-month  follow-up  was  98%  com-
lete.  During  the  ﬁrst  3  months  following  CTO-PCI,  two
atients  from  the  failure  group  underwent  a  second  attempt
t  PCI,  which  was  planned  for  the  same  target  CTO.  For
oth,  recanalization  could  not  be  achieved  and  the  second
ttempt  of  CTO-PCI  was  not  recorded  as  an  event.
As  shown  in  Table  3,  baseline  demographics  and
ngiographic  characteristics  were  broadly  similar  between
atients  who  had  a  successful  CTO  recanalization  and
atients  whose  recanalization  was  unsuccessful,  with  the
xception  of  age,  hypercholesterolaemia,  number  of  dis-
ased  vessels,  history  of  PCI  and  rate  of  patients  with  CTO
ocalized  in  the  circumﬂex  coronary  artery.
After  the  20-month  follow-up,  there  was  numerically
ower  but  non-statistically  signiﬁcant  difference  in  mortality
ates  between  patients  in  the  successful  group  and  patients
n  the  failure  group  (21.1%  vs.  9.1%;  P  =  0.34).  In  contrast,
ates  of  unstable  angina  (1.4%  vs.  4.5%  in  success  and  failure
roups,  respectively),  myocardial  infarction  (2.8%  vs.  18.2%,
espectively)  and  cardiogenic  shock  (2.8%  vs.  4.5%,  respec-
ively)  tended  to  be  higher  in  the  failure  group  (Table  4).
imilarly,  despite  optimal  medical  therapy,  symptoms  such
s  angina  CCS  ≥2  remained  more  frequent  among  the  failure
roup  (31.8%  vs.  5.6%;  P =  0.003),  and  ﬁve  (22.7%)  patients
n  this  group  required  another  PCI.  Among  patients  who  had
uccessful  recanalization,  three  (4.2%)  cases  of  restenosis
ere  recorded,  and  two  (2.8%)  patients  required  a  new  PCI
uring  follow-up  (Table  4).
MACE-free  survival  was  improved  when  patients  had
ndergone  a  successful  CTO  revascularization  (Fig.  1).  After
djustment  for  age,  sex,  hypercholesterolaemia,  diabetes,
yocardial  infarction,  peripheral  artery  disease,  PCI,  CTO
ocalization,  ACS  on  admission  and  three-vessel  disease,  the
eterminants  of  MACE  at  20  months  were  age  (HR:  1.12,  95%
I:  1.03—1.23),  history  of  myocardial  infarction  (HR:  2.77,
5%  CI:  1.22—6.25)  and  successful  CTO  recanalization  (HR:
.43,  95%  CI:  0.19—0.96;  P  =  0.039).
iscussionlderly  CTO  patients  present  a  challenge  for  interventional
ardiologists  performing  PCI.  Indeed,  previous  studies  have
eported  that  age  and  CTO  are  both  associated  with  higher
ates  of  post-procedure  complications  and  lower  rates  of
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Table  1  Baseline  characteristics  according  to  patient  age.
Variable  ≤75  years  (n  =  263)  ≥75  years  (n  =  93)  P-value
Age  (years)  60.6  ±  9.1  80.5  ±  3.8
Men  231  (87.8)  68  (73.1)  0.001
Body  mass  index  (kg/m2)  28  ±  5.3  26.3  ±  3.6  0.01
Hypertension  134  (50.9)  70  (75.3)  <0.001
Diabetes  mellitus  85  (32.3)  37  (39.8)  0.19
Hypercholesterolaemia  199  (75.7)  59  (63.4)  0.023
Current  smoking 182  (69.2) 34  (36.6) <0.001
Creatinine  clearance  (mL/min) 80 ±  27 67  ±  26 <0.001
Moderate  CKD  41  (15.6)  33  (35.5)
Severe  CKD  10  (3.8)  6  (6.5)  <0.001
Family  history  of  premature  CAD  80  (30.4)  13  (14.0)  0.002
Medical  history
Myocardial  infarction  134  (50.9)  50  (53.8)  0.64
PCI  116  (44.1)  44  (47.3)  0.59
Stroke  19  (7.2)  9  (9.7)  0.45
CABG  15  (5.7)  17  (18.3)  <0.001
Peripheral  artery  disease  63  (23.9)  23  (24.7)  0.88
Angina  CCS  ≥2  at  admission  105  (39.9)  35  (37.6)  0.75
Congestive  heart  failure  symptoms  (NYHA  class)
I  144  (54.7)  40  (43.0)
II  91  (34.6)  31  (33.3)
III  18  (6.8)  16  (17.2)
IV  10  (3.8)  6  (6.5)  0.016
Chronic  obstructive  pulmonary  disease  22  (8.4)  11  (11.8)  0.32
EuroSCORE  3  (2—6)  9  (7—10)  <0.001
Acute  coronary  syndrome  80  (30.4)  38  (40.9)  0.07
Stable  angina  88  (33.5)  29  (31.2)  0.69
Silent  myocardial  ischaemia  86  (32.7)  25  (26.9)  0.30
Left  ventricular  ejection  fraction  (%) 51 ±  11  48  ±  14  0.07
Target  vessel
Interventricular  artery  98  (37.3)  55  (59.1)  <0.001
Left  circumﬂex  artery  78  (29.7)  29  (31.2)  0.78
Right  coronary  artery  152  (57.8)  42  (45.2)  0.035
Number  of  diseased  vessels
1  73  (27.8)  15  (16.1)  0.025
2  88  (33.5)  25  (26.9)  0.24
3  102  (38.8)  53  (57.0)  0.004
Data given as number (%), mean ± standard deviation or median (interquartile range). CABG: coronary artery bypass graft; CCS: Canadian
Cardiovascular Society; CKD: chronic renal failure; CTO: chronic total occlusion; NYHA: New York Heart Association; PCI: percutaneous
coronary intervention.
sprocedural  success.  Nevertheless,  recent  studies  have  high-
lighted  that  older  patients  could  beneﬁt  the  most  from
revascularization  [4]  and  CTO-PCI  studies  have  reported  an
improvement  in  successful  procedural  recanalization  [19].




Cuccess  rate  of  CTO-PCI  has  improved  and  can  now  reach
5%  in  elderly  patients.  Moreover,  to  the  best  of  our  knowl-
dge,  this  is  one  of  the  largest  studies  to  demonstrate  an
mprovement  in  the  event-free  survival  following  successful
TO-PCI  in  unselected  patients  aged  ≥75  years.
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Table  2  Complications  within  30  days  of  PCI,  according  to  patients’  age.
Event  <75  years  (n  = 264)  ≥75  years  (n  =  93)  P-value
Hospital  death  1  (0.4)  2  (2.2)  0.11
Myocardial  infarction  0  3  (3.2)  0.017
Stroke  0  0  —
Acute  renal  failure  2  (0.8)  4  (4.3)  0.42
Haemoglobin  drop  >3  g/dL  1  (0.4)  5  (5.4)  0.005
CABG  within  30  days  of  PCI 0  2  (2.2) 0.07
MACCEa 1  (0.4) 5 (5.4) 0.005
MACCEa,  CABG  within  30  days  or  haemoglobin  drop  >3  g/dL 4  (1.5) 16  (17.2) <0.001
Values are number (%) or median (interquartile range). PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft;
MACCE: major adverse cardiac and cerebrovascular events.
a Hospital death, stroke or myocardial infarction.
Figure 1. Twenty-month outcomes for patients ≥75 years. MACE
was the composite of acute coronary syndrome, cardiogenic






















































phronic total occlusion; HR: hazard ratio; MACE: major adverse car-
iac events; PCI: percutaneous coronary intervention.
ost-procedural outcomes
s  previously  reported,  the  elderly  patients  in  our  study
ere  more  likely  to  have  calciﬁed  multivessel  CAD,  which
s  usually  associated  with  lower  rates  of  procedural  success
20—22].  Nowadays,  CTO  recanalization  can  be  achieved  in
xpert  hands  with  a  success  rate  similar  to  that  seen  in
ounger  patients.  The  procedural  techniques  used  had  to  be
dapted  for  older  patients.  For  example,  they  more  often
equired  complex  atherectomy  procedures  using  a  Rotabla-
or  because  of  an  increased  prevalence  of  calciﬁed  lesions.
etrograde  approaches  were  also  used  less  frequently  in
lder  patients,  probably  because  they  frequently  had  mul-
ivessel  CAD  restricting  the  collateral  crossing  and  the
trategies  of  PCI.  With  regard  to  the  safety  of  CTO-PCI,  we
ound  that  post-PCI  complications  were  more  frequent  in  the
lder  group.  However,  older  patients  referred  for  PCI  were
lso  at  higher  risk  of  complications  than  younger  patients:
hey  had  more  extended  CAD  and  they  had  a  higher  risk
L
T
mroﬁle,  including  severe  comorbidities,  thus  making  coro-
ary  artery  bypass  graft  surgery  unreasonable.  Regarding
inor  postoperative  complications,  we  expect  that  appro-
riated  periprocedural  management  could  reduce  haemor-
hages  or  contrast-induced  nephropathies.  In  that  way,  we
ook  preference  to  radial  approach  to  avoid  bleeding  and  we
ystematically  achieved  renal  protection  by  saline  perfusion
nfusion  before  CTO-PCI.
eneﬁts of recanalization
n  accordance  with  previous  studies,  we  demonstrate  that
ymptoms  were  better  relieved  and  that  event-free  sur-
ival  was  improved  in  patients  who  had  successful  CTO-PCI
11]. Furthermore,  our  research  highlights  that  patients  ≥75
ears  also  beneﬁt  from  CTO-PCI  recanalization.  Although  the
mproved  event-free  survival  was  mainly  due  to  a  reduced
eed  for  further  revascularization  (coronary  artery  bypass
raft  surgery  or  PCI),  we  still  demonstrated  a  reduction
n  the  rate  of  complications,  such  as  ACS  or  cardiogenic
hock,  when  CTO-PCI  was  successfully  achieved.  However,
n  contrast  to  published  ﬁndings  in  the  general  population
12,23],  survival  was  not  signiﬁcantly  associated  with  suc-
essful  CTO  recanalization  in  our  study.  Similar  results  have
merged  recently  from  the  only  other  study  of  CTO-PCI  in
lderly  patients  [24]. The  lack  of  such  studies  can  probably
e  explained  by  the  difﬁculty  in  evaluating  speciﬁc  mor-
ality  rates  in  the  elderly.  In  any  case,  the  observed  81.5%
ecrease  in  ACS  rate  and  37.8%  decrease  in  the  frequency  of
ardiogenic  shock  among  patients  who  underwent  success-
ul  CTO-PCI  support  the  hypothesis  that  CTO  recanalization
mproves  survival  [25].
To  complete  the  assessment  of  CTO-PCI  in  elderly
atients,  we  propose  that  future  studies  should  consider
atient  quality  of  life  and  analyse  cost-effectiveness.  These
robably  present  the  most  challenging  issues  as  far  as  older
atients  are  concerned.imitations
he  major  limitation  of  this  study  relates  to  the  recruit-
ent  of  the  population:  our  study  is  a  single-centre  analysis
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Table  3  Baseline  characteristics  in  patients  ≥75  years  according  to  procedural  outcome.
Variable  Procedural  failure  (n  =  22)  Procedural  success  (n  =  71)  P-value
Age  (years)  78.2  ±  3.1  81.0  ±  3.9  0.017
Men  19  (86.4)  49  (69)  0.11
Body  mass  index  (kg/m2)  26.7  ±  4.2  26.3  ±  3.4  0.91
Creatinine  clearance  (mL/min)  68  ±  27  66  ±  26  0.78
Moderate  CKD 6 (27.3)  27  (38.0)
Severe  CKD 2  (9.1) 4  (5.6) 0.60
Hypertension  16  (72.7) 54  (76.1) 0.75
Diabetes  mellitus  10  (45.5)  27  (38.0)  0.53
Hypercholesterolaemia  18  (81.8)  41  (57.7)  0.041
Current  smoking  11  (50.0)  23  (32.4)  0.13
Family  history  of  cardiovascular  disease  2  (9.1)  11  (15.5)  0.45
Medical  history
Myocardial  infarction  15  (68.2)  35  (49.3)  0.12
PCI  15  (68.2)  29  (40.8)  0.025
Stroke  2  (9.1)  7  (9.9)  0.92
CABG  6  (27.3)  11  (15.5)  0.21
Peripheral  artery  disease  8  (36.4)  15  (21.1)  0.15
Angina  CCS  ≥2  at  admission  13  (59.1)  22  (31.0)  0.09
Congestive  heart  failure  symptoms  (NYHA  class)
I  7  (31.8)  33  (46.5)
II  11  (50.0)  20  (28.2)
III  2  (9.1)  14  (19.7)
IV  2  (9.1)  4  (5.6)  0.18
Chronic  obstructive  pulmonary  disease  4  (18.2)  7  (9.9)  0.28
EuroSCORE  8.5  (6—10)  9  (7—11)  0.55
Acute  coronary  syndrome  7  (31.8)  31  (43.7)  0.46
Stable  angina  9  (40.9)  20  (28.2)  0.26
Silent  myocardial  ischaemia  5  (22.7)  20  (28.2)  0.62
Left  ventricular  ejection  fraction  (%)  49  ±  13  47  ±  14  0.60
Target  vessel
Left  anterior  descending  artery 16  (72.7)  39  (54.9)  0.14
Left  circumﬂex  artery  12  (54.5)  17  (23.9)  0.007
Right  coronary  artery 10  (44.4)  32  (45.1)  0.97
Number  of  diseased  vessels
1  0  15  (21.1) 0.018
2  7  (31.8) 18  (25.3)  0.55
3  15  (68.2) 37  (52.1) 0.19
Data given as number (%), mean ± standard deviation or median (interquartile range). CABG: coronary artery bypass graft; CCS: Canadian











Cof  patients  referred  for  CAD  invasive  management  in  a  ter-
tiary  care  centre.  Consequently,  our  ﬁndings  are  restricted
to  patients  selected  to  undergo  PCI  and  to  the  proce-
dural  outcomes  for  CTO-PCI  trained  operators.  Another
major  limitation  concerns  the  lack  of  power  in  our  anal-
ysis:  despite  being  a  high-volume  centre,  our  cohort  of
patients  ≥75  years  was  relatively  small.  Moreover,  we
included  patients  referred  for  both  stable  and  unstable  CAD.
The  small  sample  size  probably  led  to  a  lack  of  power  in
the  survival  analysis  and  in-hospital  mortality  was  prob-
ably  increased  due  to  the  inclusion  of  patients  admitted
for  ACS.  However,  our  study  is  probably  closer  to  real-
life  practice  than  a  controlled  series  or  previous  reports




orequently  affected  by  severe  comorbidities  such  as  dia-
etes,  previous  myocardial  infarction  or  chronic  kidney
isease  [24]. Similarly,  the  length  of  follow-up  was
oluntarily  reduced  to  20  months  to  better  accommo-
ate  the  question  of  elderly  patients.  Analysing  midterm
omplications  is  also  more  appropriate  when  considering
atients  ≥75  years.  The  ﬁnal  limitation  of  our  registry  was
he  absence  of  accurate  angiographic  descriptions  of  the
AD  complexity,  which  made  inter-group  comparisons  of
AD  difﬁcult.  However,  the  SYNTAX  score,  which  is  the  most
ommonly  used  classiﬁcation,  was  not  appropriate  here
ecause  most  of  our  patients  did  not  have  left-main  or  three-
essel  CAD.  Moreover  it  seems  to  be  of  limited  use  in  the  ﬁeld
f  CTO.
20  
Table  4  Outcomes  at  20  months  for  patients  ≥75  years
according  to  procedural  outcome.
Event  Procedural
failure
(n  =  22)
Procedural
success
(n  =  71)
P-value
Death  2  (9.1)  15  (21.1)  0.34
Myocardial
infarction
4  (18.2) 2  (2.8)  0.026
Unstable  angina  1  (4.5)  1  (1.4)  0.42
Cardiogenic
shock
1  (4.5)  2  (2.8)  0.56




5  (22.7)  2  (2.8)  0.007


























coronary artery occlusion. Zhonghua Xin Xue Guan Bing Za Zhionclusions
ur  study  has  demonstrated  the  feasibility  of  CTO-PCI  in
atients  ≥75  years,  despite  a  slight  increase  in  the  rate
f  postoperative  complications.  We  have  shown  that  suc-
essful  CTO-PCI  recanalization  is  associated  with  improved
0-month  event-free  survival.  These  results  suggest  that
TO-PCI  could  be  an  interesting  alternative  strategy  to  treat
elected  elderly  patients  who  require  myocardial  revascula-
ization.
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